Covid19_manual_annotation  

Documents (39) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 32418532 Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA 5.69 KB 2020-06-04 27 567 2021-06-07
2020PubMed@AikoHIRAKI re32807241 Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfraction 8.34 KB 2021-06-10 1 471 2021-06-11
2020PubMed@AikoHIRAKI re32418532 Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SA 5.69 KB 2021-06-07 1 484 2021-06-07
PubMed 32807241 Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfraction 8.33 KB 2020-08-31 22 420 2021-06-04
2020PubMed@AikoHIRAKI re32610873 Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized p 5.41 KB 2021-06-08 1 444 2021-06-11
PubMed 32610873 Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized p 5.41 KB 2020-09-23 23 416 2021-06-03
2020PubMed@AikoHIRAKI re33213530 Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structure 6.59 KB 2021-06-08 1 332 2021-06-11
PubMed 32744052 IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory eff 4.3 KB 2020-08-18 24 446 2021-06-04
PubMed 33213530 Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structure 6.58 KB 2021-01-17 15 354 2021-06-03
2020PubMed@AikoHIRAKI re32744052 IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory eff 4.3 KB 2021-06-08 1 404 2021-06-08